Imunon, Inc. Common Stock (IMNN) is a publicly traded Healthcare sector company. As of July 21, 2026, IMNN trades at $1.61 with a market cap of $7.44M and a P/E ratio of -0.24. IMNN moved -5.65% today. Year to date, IMNN is -56.17%; over the trailing twelve months it is -77.14%. Its 52-week range spans $1.59 to $41.22. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces IMNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for IMNN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.61 |
| Market Cap | $7.44M |
| P/E Ratio | -0.24 |
| EPS | $-6.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.22 |
| 52-Week Low | $1.59 |
| Volume | 3.53M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-14.50M |
| Gross Margin | 0.00% |
1 analysts cover IMNN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.